Showing results (161-170 of 269) with videos related to

Sort By:
Pageof 27
JCO Global Oncology|April 22, 2020
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated CholangiocarcinomaSarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, et al.
Medcomm|June 19, 2023
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphomaYali Wang, Wenbo Zhou, Jianfeng Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 3, 2018
Population genomics in South East Asia captures unexpectedly high carrier frequency for treatable inherited disordersYasmin Bylstra, Jyn Ling Kuan, Weng Khong Lim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 16, 2024
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian CancerShini Liu, Peng Deng, Zhaoliang Yu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 10, 2018
Correction: Population genomics in South East Asia captures unexpectedly high carrier frequency for treatable inherited disordersYasmin Bylstra, Jyn Ling Kuan, Weng Khong Lim, et al.
Frontiers in Molecular Biosciences|October 10, 2022
A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samplesCedric Chuan-Young Ng, Sandy Lim, Abner Herbert Lim, et al.
Cancer|April 30, 2009
Innovations and challenges in renal cancer: summary statement from the Third Cambridge ConferenceMichael B Atkins, Ronald M Bukowski, Bernard J Escudier, et al.
Communications Biology|April 27, 2023
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcomaJui Wan Loh, Jing Yi Lee, Abner Herbert Lim, et al.
The Journal of Clinical Investigation|November 29, 2016
Dual modulation of MCL-1 and mTOR determines the response to sunitinibMohamed Elgendy, Amal Kamal Abdel-Aziz, Salvatore Lorenzo Renne, et al.
JCI Insight|June 6, 2024
4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancerJiaxin Yin, Jianfeng Chen, Jing Han Hong, et al.
Pageof 27